Home > Journals > Giornale Italiano di Dermatologia e Venereologia > Past Issues > Giornale Italiano di Dermatologia e Venereologia 1998 June;133(3) > Giornale Italiano di Dermatologia e Venereologia 1998 June;133(3):225-7

CURRENT ISSUEGIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA

A Journal on Dermatology and Sexually Transmitted Diseases


Official Journal of the Italian Society of Dermatology and Sexually Transmitted Diseases
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,014


eTOC

 

THERAPEUTICAL NOTES  


Giornale Italiano di Dermatologia e Venereologia 1998 June;133(3):225-7

language: English

Treat­ment of sca­bies ­with bis-­butyl-car­boe­thy­lene

Zorzi F.

Insti­tute of Der­mat­o­log­i­cal Sci­enc­es, ­IRCCS, Uni­ver­sity of ­Milan, Ospe­dale Mag­giore, ­Milan


PDF  REPRINTS


Back­ground. ­This ­study was ­designed to eval­u­ate the effi­ca­cy of a bis-­butyl-car­boe­thy­lene prep­ar­a­tion in elim­i­nat­ing the Sar­coptes sca­biei ­mite in ­patients ­with sca­bies infec­tion.
Meth­ods. Twen­ty-two peo­ple ­with sca­bies (8 ­females, 14 ­males), ­aged ­from 8 ­months to 60 ­years, ­were treat­ed ­with two appli­ca­tions of bis-­butyl-car­boe­thy­lene. ­After ­three ­days, the ­patients ­were re-exam­ined and if the ­mite was ­still ­present fur­ther appli­ca­tions ­were pre­scribed. All ­patients ­were exam­ined one ­month ­after the ­last appli­ca­tion.
­Results. Sar­coptes sca­biei was elim­i­nat­ed in all 22 ­patients (100%): in 18 ­patients (81.8%) ­after one ­cycle of treat­ment (two appli­ca­tions), in two (9.1%) ­after ­another treat­ment and in two (9.1%) ­with two fur­ther treat­ments ­after the ­first ­cycle. The bis-­butyl-car­boe­thy­lene prep­ar­a­tion was ­well tol­er­at­ed by 20 ­patients (90.9%), and ­only two (9.1%) pre­sent­ed irri­ta­tive ecze­ma.
Con­clu­sions. The bis-­butyl-car­boe­thy­lene ­oppears to be a use­ful ­tool in the ther­a­py of sca­bies.

top of page